Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor
- PMID: 9840933
- DOI: 10.1038/sj.onc.1202209
Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor
Abstract
The Met tyrosine kinase receptor has been implicated in human cancer. Here we have examined the signaling requirements of three oncogenic forms of this molecule: wild type Met in response to ligand/autocrine stimulation, Met which has been mutationally activated, and Tpr-Met (a constitutively active truncated Met fusion protein). Previous studies have demonstrated the importance of a Grb2 binding site, and of specific tyrosine residues (i.e. Y8,9 and Y14,15) for Met function, and we have now explored the relevance of these and other sites for oncogenic Met signaling. Following substitution of various intracellular tyrosines for phenylalanine, we find that the transforming activity of each Met oncogene is dependent upon tyrosines Y8,9 and Y14,15, in addition to two novel tyrosines (Y6 and Y10) not previously implicated in Met signaling. Tyrosines Y6 and Y10 influence a variety of Met-mediated responses both in vitro (transformation, mitogenicity and invasion), and in vivo (tumorigenicity and metastasis). We also show that Tpr-Met is much more dependent on its Grb2 binding site for biological activity than are the other oncogenic forms of the Met receptor. Thus, although the three Met oncogenes examined are similar in their dependency on a number of specific tyrosines for activity, the signaling strategy employed by Tpr-Met can be differentiated from that of the other two.
Similar articles
-
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.Oncogene. 2002 Mar 14;21(12):1800-11. doi: 10.1038/sj.onc.1205261. Oncogene. 2002. PMID: 11896612
-
Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.Oncogene. 1999 Feb 4;18(5):1139-46. doi: 10.1038/sj.onc.1202607. Oncogene. 1999. PMID: 10022119
-
Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.Oncogene. 1995 Jan 19;10(2):237-49. Oncogene. 1995. PMID: 7838524
-
Met receptor tyrosine kinase: enhanced signaling through adapter proteins.Oncogene. 2000 Nov 20;19(49):5582-9. doi: 10.1038/sj.onc.1203859. Oncogene. 2000. PMID: 11114738 Review.
-
MET signalling: principles and functions in development, organ regeneration and cancer.Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48. doi: 10.1038/nrm3012. Nat Rev Mol Cell Biol. 2010. PMID: 21102609 Review.
Cited by
-
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.Mol Cell Biol. 2000 Nov;20(22):8513-25. doi: 10.1128/MCB.20.22.8513-8525.2000. Mol Cell Biol. 2000. PMID: 11046147 Free PMC article.
-
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.J Clin Invest. 2002 Apr;109(7):863-7. doi: 10.1172/JCI15418. J Clin Invest. 2002. PMID: 11927612 Free PMC article. Review. No abstract available.
-
Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.Am J Pathol. 2000 Nov;157(5):1563-73. doi: 10.1016/S0002-9440(10)64793-1. Am J Pathol. 2000. PMID: 11073815 Free PMC article.
-
Progesterone receptor A and c-Met mediates spheroids-endometrium attachment.Reprod Biol Endocrinol. 2009 Feb 16;7:14. doi: 10.1186/1477-7827-7-14. Reprod Biol Endocrinol. 2009. PMID: 19220894 Free PMC article.
-
Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.Mol Cell Biol. 2000 May;20(10):3482-96. doi: 10.1128/MCB.20.10.3482-3496.2000. Mol Cell Biol. 2000. PMID: 10779338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
